Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 6/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 2/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | PRKCG | P05129 | 1/20 | 0.35 |
| ▸ | PRKCB | P05771 | 1/20 | 0.35 |
| ▸ | PRKCH | P24723 | 1/20 | 0.35 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.35 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.35 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.35 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | NAAA | Q02083 | 4/20 | 0.35 |
| ▸ | CNR1 | P21554 | 4/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26754371 | 0.86 | CYP3A4 (0.37) | DAGLAMGLLBRD4PRKCAPRKD3 | |
| SCHEMBL13310153 | 0.83 | TSHR (0.39) | DAGLAMGLLBRD4PRKCAPRKD3 | |
| SCHEMBL10073528 | 0.83 | TSHR (0.39) | DAGLAMGLLBRD4PRKCAPRKD3 | |
| SCHEMBL10083943 | 0.83 | TSHR (0.39) | DAGLAMGLLBRD4PRKCAPRKD3 | |
| SCHEMBL23797036 | 0.74 | — | — | |
| SCHEMBL20625355 | 0.74 | — | — | |
| SCHEMBL26365550 | 0.72 | CYP3A4 (0.36) | BRD4GAACYP3A4MAPTCYP2C9 | |
| SCHEMBL26754370 | 0.71 | HSD17B10 (0.46) | BRD4GAACYP3A4MAPTCYP2C9 | |
| SCHEMBL10067538 | 0.69 | PLA2G6 (0.47) | DAGLAMGLLPRKCAPRKD3PRKCG | |
| SCHEMBL19930130 | 0.68 | HTT (0.37) | BRD4GAAHSD17B10USP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | IDH1, IDH2, IDH3A | DAGLA 1546/4885MGLL 2378/4885BRD4 3294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.